Cancer Home > Lazanda and Breastfeeding
The manufacturer of Lazanda (fentanyl nasal spray) recommends that women avoid using this medication while breastfeeding. Although the drug has not been adequately studied in nursing women, it is known that the active ingredient in the drug does pass through breast milk in small amounts. This may cause potentially serious problems in the infant, such as poor feeding or difficulty breathing.
Can Breastfeeding Women Use Lazanda?Lazanda® (fentanyl nasal spray) is a prescription medication approved for breakthrough pain in adults with cancer. Lazanda contains fentanyl, a strong narcotic pain medication. This drug is known to pass through breast milk, and the manufacturer recommends that women avoid using Lazanda while nursing.
More Information on Lazanda and BreastfeedingLazanda has not been adequately studied in breastfeeding women. Fentanyl, the active ingredient in Lazanda, is known to pass through breast milk in small amounts. While the amount of fentanyl passed through is thought to be small, most studies have looked at single fentanyl doses. There is very little information available about the effects of repeated fentanyl doses, which would be the case with Lazanda use.
- Changes in behavior, such as irritability, jitteriness, or restlessness
- Excessive or high-pitched crying
- Poor feeding
- Increased muscle tone